Extended Data Fig. 1: Validation of predictive value of ctDNA MRD after chemoradiation therapy (CRT) alone. | Nature Cancer

Extended Data Fig. 1: Validation of predictive value of ctDNA MRD after chemoradiation therapy (CRT) alone.

From: Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer

Extended Data Fig. 1

a, Event chart showing timing of therapy, progression based on RECIST 1.1 evaluation of imaging, and results of ctDNA testing for each patient. b, Kaplan-Meier analysis of freedom from progression stratified by ctDNA detection within 4 months of completing CRT (n=6 not detected, n=6 detected). P values were calculated using a two-sided log-rank test.

Source data

Back to article page